The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand
- 1 April 2008
- Vol. 26 (22) , 2746-2752
- https://doi.org/10.1016/j.vaccine.2008.03.017
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006
- The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal diseaseVaccine, 2005
- MeNZB™: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strainVaccine, 2005
- From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal diseaseVaccine, 2005
- A 10‐year serogroup B meningococcal disease epidemic in New Zealand: Descriptive epidemiology, 1991–2000Journal of Paediatrics and Child Health, 2001
- Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal VaccinesJAMA, 1999
- Causal or Casual?Drug Safety, 1997
- Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, ChileVaccine, 1995
- Harmonisation in PharmacovigilanceDrug Safety, 1994
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991